콘텐츠로 건너뛰기
Merck
  • Plasma protein changes in rats treated with hypolipidaemic drugs and with phthalate esters.

Plasma protein changes in rats treated with hypolipidaemic drugs and with phthalate esters.

Human toxicology (1985-05-01)
R H Hinton, S C Price, F E Mitchell, A Mann, D E Hall, J W Bridges
초록

Treatment of rats with hypolipidaemic drugs or with the plasticizer di-2-ethyl hexyl phthalate caused significant alterations in the concentration of certain plasma proteins. Certain proteins showed dose-dependent increases, in other cases the plasma concentrations fell in treated animals. The changes were quite distinct from the changes in plasma proteins which occur during the acute-phase response to inflammatory agents. Some changes appeared specific to agents which produce peroxisome proliferation in liver, other alterations appeared associated with mild, but sustained, liver injury.

MATERIALS
제품 번호
브랜드
제품 설명

Sigma-Aldrich
Di-n-octyl phthalate, ≥98.0% (GC)
Supelco
Di-n-octyl phthalate, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
Supelco
Di-n-octyl phthalate, analytical standard